← SynDRA
CLASCOTERONE
SynDRA canonical compound SYN0038329 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Approval status | Approved · Rx |
|---|
| Primary target(s) | AR |
|---|
| Mechanism of action | androgen receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
Drug classes
- Androgen Receptor Antagonists
- Androgen Receptor Inhibitor
ATC classes
- D10A · ANTI-ACNE PREPARATIONS FOR TOPICAL USE
Cross-references
Synonyms
- winlevi
- CB-03-01
- breezula
- cortexolone 17alpha-propionate
- Clascoterona
- Cortexolone 17.alpha.-propionate
- Cortodoxone 17.alpha.-propionate
- Breezula
- Winlevi
- XN7MM8XG2M
- Cortexolone 17alpha-propionate
- Pregn-4-ene-3,20-dione, 21-hydroxy-17-(1-oxopropoxy)-
- Cortodoxone 17alpha-propionate
- Pregn-4-ene-3,20-dione, 17,21-dihydroxy-, 17-propionate
- clascoterona
- clascoteronum
- RefChem:54840
- DTXCID70422699
- Clascoterone [USAN]
- Clascoterone (USAN)
- UNII-XN7MM8XG2M
- Winlevi (TN)
- CLASCOTERONE [MI]
- CLASCOTERONE [INN]
- CLASCOTERONE [WHO-DD]
- orb1304286
- orb3141181
- SCHEMBL1231152
- Clascoterone - Bio-X trade mark
- GTPL11215
- CLASCOTERONE [ORANGE BOOK]
- GLXC-04691
- EX-A1953
- EBC-26959
- MSK170224
- s6896
- AKOS030526694
- AT22231
Reported adverse events
- Erythema
- Pruritus
- Skin atrophy
- Telangiectasia
Look up CLASCOTERONE in the interactive SynDRA portal →